The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells

Research output: Contribution to journalArticle

Abstract

Objective: HIV-1 Tat can be released by infected cells and exert various extracellular functions on bystander cells, possibly contributing to immunodeficiency. In order to investigate whether exogenous Tat can affect antigen presentation, the effects of synthetic Tat on the function of dendritic cells displaying antigen presenting cell phenotype were studied. Design: Cultured dendritic cells were challenged with apoptotic bodies and monitored for cell engulfment and free intracellular calcium ([Ca2+](i)) increase. The effect of synthetic HIV-1 Tat and its RGD-containing domain (peptide 65-80) or basic domain (peptide 46-60) on both functions was investigated. Methods: Dendritic cells were obtained by culture of monocytes with granulocyte-macrophage colony-stimulating factor. Apoptosis was induced in Jurkat cells by sublethal irradiation. Engulfment of radiolabelled apoptotic bodies by dendritic cells was obtained by a 45 min co-incubation at 37°C. Non-ingested apoptotic bodies were removed and cell-associated radioactivity evaluated in a γ-counter after cell lysis. Single cell analysis of calcium fluxes was performed by video-microscopy and ratio-imaging, after cell staining with the fluorescent calcium chelator FURA-2. Results: Apoptotic bodies were engulfed by dendritic cells: this process was accompanied by [Ca2+](i) rise. Synthetic HIV-1 Tat inhibited both apoptotic body engulfment and [Ca2+](i) increase. The same inhibition was obtained with the RGD-containing domain (peptide 65-80), but not with the basic domain (peptide 46-60) of Tat, suggesting the involvement of an integrin. This integrin is likely to be α(v)β3, since RGD-containing peptides from vitronectin, but not from fibronectin, inhibited apoptotic body engulfment. Furthermore, both HIV-1 Tat and its 65-80 peptide blocked [Ca2+](i) increase due to β3-integrin cross-linking. Conclusions: Our results support a role for HIV-1 Tat in decreasing the function of dendritic cells, possibly impairing antigen presentation.

Original languageEnglish
Pages (from-to)1227-1235
Number of pages9
JournalAIDS (London, England)
Volume11
Issue number10
DOIs
Publication statusPublished - 1997

Fingerprint

Dendritic Cells
HIV-1
Integrins
Antigen Presentation
Single-Cell Analysis
Calcium
Vitronectin
Video Microscopy
Jurkat Cells
Antigen-Presenting Cells
Granulocyte-Macrophage Colony-Stimulating Factor
Fibronectins
Radioactivity
Extracellular Vesicles
Monocytes
Cultured Cells
Apoptosis
Staining and Labeling
Phenotype
Peptides

Keywords

  • Calcium mobilization
  • Dendritic cell function
  • Engulfment
  • HIV-1 Tat
  • Integrin signalling

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells. / Zocchi, M. Raffaella; Poggi, Alessandro; Rubartelli, Anna.

In: AIDS (London, England), Vol. 11, No. 10, 1997, p. 1227-1235.

Research output: Contribution to journalArticle

@article{e8f31fede0254f3289b3900a14daa3c3,
title = "The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells",
abstract = "Objective: HIV-1 Tat can be released by infected cells and exert various extracellular functions on bystander cells, possibly contributing to immunodeficiency. In order to investigate whether exogenous Tat can affect antigen presentation, the effects of synthetic Tat on the function of dendritic cells displaying antigen presenting cell phenotype were studied. Design: Cultured dendritic cells were challenged with apoptotic bodies and monitored for cell engulfment and free intracellular calcium ([Ca2+](i)) increase. The effect of synthetic HIV-1 Tat and its RGD-containing domain (peptide 65-80) or basic domain (peptide 46-60) on both functions was investigated. Methods: Dendritic cells were obtained by culture of monocytes with granulocyte-macrophage colony-stimulating factor. Apoptosis was induced in Jurkat cells by sublethal irradiation. Engulfment of radiolabelled apoptotic bodies by dendritic cells was obtained by a 45 min co-incubation at 37°C. Non-ingested apoptotic bodies were removed and cell-associated radioactivity evaluated in a γ-counter after cell lysis. Single cell analysis of calcium fluxes was performed by video-microscopy and ratio-imaging, after cell staining with the fluorescent calcium chelator FURA-2. Results: Apoptotic bodies were engulfed by dendritic cells: this process was accompanied by [Ca2+](i) rise. Synthetic HIV-1 Tat inhibited both apoptotic body engulfment and [Ca2+](i) increase. The same inhibition was obtained with the RGD-containing domain (peptide 65-80), but not with the basic domain (peptide 46-60) of Tat, suggesting the involvement of an integrin. This integrin is likely to be α(v)β3, since RGD-containing peptides from vitronectin, but not from fibronectin, inhibited apoptotic body engulfment. Furthermore, both HIV-1 Tat and its 65-80 peptide blocked [Ca2+](i) increase due to β3-integrin cross-linking. Conclusions: Our results support a role for HIV-1 Tat in decreasing the function of dendritic cells, possibly impairing antigen presentation.",
keywords = "Calcium mobilization, Dendritic cell function, Engulfment, HIV-1 Tat, Integrin signalling",
author = "Zocchi, {M. Raffaella} and Alessandro Poggi and Anna Rubartelli",
year = "1997",
doi = "10.1097/00002030-199710000-00005",
language = "English",
volume = "11",
pages = "1227--1235",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "10",

}

TY - JOUR

T1 - The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells

AU - Zocchi, M. Raffaella

AU - Poggi, Alessandro

AU - Rubartelli, Anna

PY - 1997

Y1 - 1997

N2 - Objective: HIV-1 Tat can be released by infected cells and exert various extracellular functions on bystander cells, possibly contributing to immunodeficiency. In order to investigate whether exogenous Tat can affect antigen presentation, the effects of synthetic Tat on the function of dendritic cells displaying antigen presenting cell phenotype were studied. Design: Cultured dendritic cells were challenged with apoptotic bodies and monitored for cell engulfment and free intracellular calcium ([Ca2+](i)) increase. The effect of synthetic HIV-1 Tat and its RGD-containing domain (peptide 65-80) or basic domain (peptide 46-60) on both functions was investigated. Methods: Dendritic cells were obtained by culture of monocytes with granulocyte-macrophage colony-stimulating factor. Apoptosis was induced in Jurkat cells by sublethal irradiation. Engulfment of radiolabelled apoptotic bodies by dendritic cells was obtained by a 45 min co-incubation at 37°C. Non-ingested apoptotic bodies were removed and cell-associated radioactivity evaluated in a γ-counter after cell lysis. Single cell analysis of calcium fluxes was performed by video-microscopy and ratio-imaging, after cell staining with the fluorescent calcium chelator FURA-2. Results: Apoptotic bodies were engulfed by dendritic cells: this process was accompanied by [Ca2+](i) rise. Synthetic HIV-1 Tat inhibited both apoptotic body engulfment and [Ca2+](i) increase. The same inhibition was obtained with the RGD-containing domain (peptide 65-80), but not with the basic domain (peptide 46-60) of Tat, suggesting the involvement of an integrin. This integrin is likely to be α(v)β3, since RGD-containing peptides from vitronectin, but not from fibronectin, inhibited apoptotic body engulfment. Furthermore, both HIV-1 Tat and its 65-80 peptide blocked [Ca2+](i) increase due to β3-integrin cross-linking. Conclusions: Our results support a role for HIV-1 Tat in decreasing the function of dendritic cells, possibly impairing antigen presentation.

AB - Objective: HIV-1 Tat can be released by infected cells and exert various extracellular functions on bystander cells, possibly contributing to immunodeficiency. In order to investigate whether exogenous Tat can affect antigen presentation, the effects of synthetic Tat on the function of dendritic cells displaying antigen presenting cell phenotype were studied. Design: Cultured dendritic cells were challenged with apoptotic bodies and monitored for cell engulfment and free intracellular calcium ([Ca2+](i)) increase. The effect of synthetic HIV-1 Tat and its RGD-containing domain (peptide 65-80) or basic domain (peptide 46-60) on both functions was investigated. Methods: Dendritic cells were obtained by culture of monocytes with granulocyte-macrophage colony-stimulating factor. Apoptosis was induced in Jurkat cells by sublethal irradiation. Engulfment of radiolabelled apoptotic bodies by dendritic cells was obtained by a 45 min co-incubation at 37°C. Non-ingested apoptotic bodies were removed and cell-associated radioactivity evaluated in a γ-counter after cell lysis. Single cell analysis of calcium fluxes was performed by video-microscopy and ratio-imaging, after cell staining with the fluorescent calcium chelator FURA-2. Results: Apoptotic bodies were engulfed by dendritic cells: this process was accompanied by [Ca2+](i) rise. Synthetic HIV-1 Tat inhibited both apoptotic body engulfment and [Ca2+](i) increase. The same inhibition was obtained with the RGD-containing domain (peptide 65-80), but not with the basic domain (peptide 46-60) of Tat, suggesting the involvement of an integrin. This integrin is likely to be α(v)β3, since RGD-containing peptides from vitronectin, but not from fibronectin, inhibited apoptotic body engulfment. Furthermore, both HIV-1 Tat and its 65-80 peptide blocked [Ca2+](i) increase due to β3-integrin cross-linking. Conclusions: Our results support a role for HIV-1 Tat in decreasing the function of dendritic cells, possibly impairing antigen presentation.

KW - Calcium mobilization

KW - Dendritic cell function

KW - Engulfment

KW - HIV-1 Tat

KW - Integrin signalling

UR - http://www.scopus.com/inward/record.url?scp=0030791368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030791368&partnerID=8YFLogxK

U2 - 10.1097/00002030-199710000-00005

DO - 10.1097/00002030-199710000-00005

M3 - Article

C2 - 9256940

AN - SCOPUS:0030791368

VL - 11

SP - 1227

EP - 1235

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 10

ER -